Bacteria naturally evolve to resist drugs, but they are evolving faster and faster due to the overuse of common antibiotics in humans and animals, including in medical treatment and on farms. Most previous research has focused on the human costs of antibiotic resistance, but Wednesday’s report places a price tag on the threat. The analysis, produced by the RAND Corporation, a public policy research organization, and the accounting firm KPMG, projects that unless antimicrobial resistance (AMR) is prioritized and defeated, an average of 10 million people will die every year by 2050.